Anti-ENPP4/ NPP4 monoclonal antibody

Anti-ENPP4/ NPP4 antibody for FACS & in-vivo assay

Target products collectionGo to ENPP4/ENPP4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0410-Ab-1/ GM-Tg-hg-MP0410-Ab-2Anti-Human ENPP4 monoclonal antibodyHuman
GM-Tg-rg-MP0410-Ab-1/ GM-Tg-rg-MP0410-Ab-2Anti-Rat ENPP4 monoclonal antibodyRat
GM-Tg-mg-MP0410-Ab-1/ GM-Tg-mg-MP0410-Ab-2Anti-Mouse ENPP4 monoclonal antibodyMouse
GM-Tg-cynog-MP0410-Ab-1/ GM-Tg-cynog-MP0410-Ab-2Anti-Cynomolgus/ Rhesus macaque ENPP4 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0410-Ab-1/ GM-Tg-felg-MP0410-Ab-2Anti-Feline ENPP4 monoclonal antibodyFeline
GM-Tg-cang-MP0410-Ab-1/ GM-Tg-cang-MP0410-Ab-2Anti-Canine ENPP4 monoclonal antibodyCanine
GM-Tg-bovg-MP0410-Ab-1/ GM-Tg-bovg-MP0410-Ab-2Anti-Bovine ENPP4 monoclonal antibodyBovine
GM-Tg-equg-MP0410-Ab-1/ GM-Tg-equg-MP0410-Ab-2Anti-Equine ENPP4 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0410-Ab-1/ GM-Tg-hg-MP0410-Ab-2; GM-Tg-rg-MP0410-Ab-1/ GM-Tg-rg-MP0410-Ab-2;
GM-Tg-mg-MP0410-Ab-1/ GM-Tg-mg-MP0410-Ab-2; GM-Tg-cynog-MP0410-Ab-1/ GM-Tg-cynog-MP0410-Ab-2;
GM-Tg-felg-MP0410-Ab-1/ GM-Tg-felg-MP0410-Ab-2; GM-Tg-cang-MP0410-Ab-1/ GM-Tg-cang-MP0410-Ab-2;
GM-Tg-bovg-MP0410-Ab-1/ GM-Tg-bovg-MP0410-Ab-2; GM-Tg-equg-MP0410-Ab-1/ GM-Tg-equg-MP0410-Ab-2
Products NameAnti-ENPP4 monoclonal antibody
Formatmab
Target NameENPP4
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-ENPP4 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species ENPP4/ NPP4 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP0410
    Target NameENPP4
    Gene ID22875,224794,301261,703680,481823,101089863,538583,100068264
    Gene Symbol and Synonyms4933413N07Rik,E-NPP 4,ENPP4,Gm90,NPP4
    Uniprot AccessionQ9Y6X5,A2VDP5
    Uniprot Entry NameENPP4_HUMAN,ENPP4_BOVIN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000001561
    Target ClassificationN/A

    The target: ENPP4, gene name: ENPP4, also named as NPP4. Enables bis(5'-adenosyl)-triphosphatase activity. Involved in positive regulation of blood coagulation and purine ribonucleoside catabolic process. Located in extracellular exosome and membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.